Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients.
Nat Commun
; 15(1): 1652, 2024 Feb 23.
Article
in En
| MEDLINE
| ID: mdl-38396069
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cytidine
/
SARS-CoV-2
/
COVID-19
/
Hydroxylamines
Limits:
Adult
/
Humans
Language:
En
Journal:
Nat Commun
Journal subject:
BIOLOGIA
/
CIENCIA
Year:
2024
Document type:
Article
Affiliation country:
Reino Unido
Country of publication:
Reino Unido